Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates X Gu, Q Ebrahem, RZ Mahfouz, M Hasipek, F Enane, T Radivoyevitch, ... The Journal of clinical investigation 128 (10), 4260-4279, 2018 | 110 | 2018 |
Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells FO Enane, Y Saunthararajah, M Korc Cell death & disease 9 (9), 912, 2018 | 75 | 2018 |
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition FO Enane, WH Shuen, X Gu, E Quteba, B Przychodzen, H Makishima, ... The Journal of clinical investigation 127 (9), 3527-3542, 2017 | 49 | 2017 |
PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation X Gu, F Enane, R Tohme, C Schuerger, T Radivoyevitch, Y Parker, ... Cell reports 36 (12), 2021 | 14 | 2021 |
The mechanism by which mutant nucleophosmin (NPM1) creates leukemic self-renewal is readily reversed X Gu, RZ Mahfouz, Q Ebrahem, F Enane, T Radivoyevitch, MJ Clemente, ... Blood 128 (22), 444, 2016 | 5 | 2016 |
A specific mechanism by which NPM1 mutations impede myeloid differentiation also explains the link with DNMT3A mutation X Gu, RZ Mahfouz, F Enane, Z Hu, MJ Clemente, BP Przychodzen, ... Blood 122 (21), 1254, 2013 | 5 | 2013 |
PHF6-somatic mutations and their role in pathophysiology of MDS and AML B Przychodzen, X Gu, D You, CM Hirsch, MJ Clemente, AD Viny, ... Blood 126 (23), 1259, 2015 | 4 | 2015 |
Purification of human skin N-deacetylase MO Longas, J Trinkle-Pereira, K Cheairs, TO Ojo, F Enane, D Warner Glycobiology 24 (11), 1162-1162, 2014 | 3 | 2014 |
The Mechanisms By Which Mutant-NPM1 Uncouples Differentiation from Proliferation Are Reversed By Several Drugs, Enabling Rational Multi-Component Non-Cytotoxic Differentiation … X Gu, Q Ebrahem, RZ Mahfouz, M Hasipek, F Enane, T Radivoyevitch, ... Blood 130, 878, 2017 | 1 | 2017 |
PBRM1 inactivation in renal cell cancer alters master transcription factor hub composition to repress instead of activate epithelial-differentiation X Gu, F Enane, R Mahfouz, T Radivoyevitch, B Przychodzen, Y Parker, ... Cancer Research 77 (13_Supplement), 3520-3520, 2017 | 1 | 2017 |
Hepatocyte Differentiation and Hepatocellular Carcinoma: Rationale for p53 Independent Therapy FO Enane Case Western Reserve University, 2017 | 1 | 2017 |
Cytoplasmic localization of PU. 1 with mutated NPM1 causes myeloid differentiation arrest X Gu, R Mahfouz, J Zhang, F Enane, Z Hu, T Radivoyevitch, D Wald, ... Cancer Research 76 (14_Supplement), 2872-2872, 2016 | 1 | 2016 |
Advancing non-cytotoxic DNMT1-targeting to treat chemorefractory pancreatic cancer R Tohme, F Enane, C Schuerger, X Gu, M Fishel, J Pink, D Lindner, ... Cancer Research 81 (13_Supplement), 1088-1088, 2021 | | 2021 |
PBRM1 Loss in Kidney Cancer Unbalances the Kidney Lineage Master Transcription Factor Hub to Repress Terminal Epithelial Fates X Gu, F Enane, C Schuerger, T Radivoyevitch, Y Parker, E Zuberi, ... Available at SSRN 3459578, 2019 | | 2019 |
Perturbations in tat-interacting protein 30 (TIP30) levels contribute to pancreatic cancer aggressiveness IE Imasuen-Williams, F Enane, M Korc Cancer Research 78 (13_Supplement), 4079-4079, 2018 | | 2018 |
Differentiation therapy and the mechanisms that terminate malignant proliferation FO Enane, X Gu, M Korc, Y Saunthararajah Cancer Research 78 (13_Supplement), 2917-2917, 2018 | | 2018 |
Translational significance of a newly identified hepatocellular carcinoma tumor suppressor gene on chromosome 8p. HC Toh, F Enane, M Teo, H Makishima, JA Ng, CL Chee, SF Ang, KH Lim, ... Journal of Clinical Oncology 31 (15_suppl), e15097-e15097, 2013 | | 2013 |
Frequent mutation and deletion of GATA4 in hepatocellular carcinoma represses proliferation terminating late-maturation genes CEBPD and HNF4A by reversible epigenetic mechanisms. FO Enane, M Teo, H Makishima, Z Hu, HC Toh, Y Saunthararajah, J Ng, ... Cancer Research 73 (8_Supplement), 3518-3518, 2013 | | 2013 |
Peakfit: An Aid to Resolve S= O Sulfonate Bands on the Fourier Transform Infrared Spectra of Heparin F Enane, M Longas GLYCOBIOLOGY 20 (11), 1507-1508, 2010 | | 2010 |